According to GlobalData, ALLPLEX is one of 160 product lines sold in the US respiratory disease tests market; these product lines are sold by 75 different manufacturers. The price of the ALLPLEX device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Respiratory Disease Tests - Seegene Inc - ALLPLEX

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.

In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Seegene apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.

Seegene overview

Seegene Inc (Seegene) is a medical device company that develops molecular diagnostic reagents. The company offering products includes Seeplex, anyplex and magicplex among others in the areas of Respiratory Infections, Gastrointestinal Tract Infections, Sexually Transmitted Infections, Human Papillomavirus Infections, Tuberculosis, Sepsis and Meningitis, among others. It develops ACP, DPO, READ, MuDT and TOCE technologies that enable to detect multiple pathogens in single reactions using Real-time PCR methods. Seegene’s IVD reagents are used in testing respiratory pathogens, gastrointestinal pathogens, sexually transmitted infections, human papillomavirus, tuberculosis and sepsis and meningitis pathogen, among others. The company serves commercial laboratories, DNA chip-based companies and molecular diagnostic companies. It operates in the US, Canada, South Korea, Brazil, Mexico, Italy, Middle East, and Germany. Seegene is headquartered in Seoul, South Korea.

For a complete picture of ALLPLEX, Respiratory Disease Tests pricing in the US, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.